Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ductal Carcinoma in Situ
Sentinel lymph node biopsy should be utilized in ductal cardinoma in situ
November 24th, 2005
Researchers recommend that sentinel lymph node biopsy should be selectively utilized in ductal cardinoma in situ. The purpose of a study by scientists in the United States was "to further clarify the incidence of ductal carcinoma in situ (DCIS) patients that are upstaged upon final pathology and/or have metastatic disease in the axilla. All patients were diagnosed with DCIS or DCIS with micro invasion (DCISm) on their diagnostic biopsy and received a sentinel lymph node (SLN) biopsy between 1994 and 2004." C. Wilkie and colleagues divided "six hundred seventy-five patients into 613 patients with DCIS and 62 patients with DCISm. Sixty-six of 675 (10%)...
Source: Women's Health Weekly (2005-11-24)
|
